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Abstract
We have examined the role of cell surface glycosaminoglycans in cell
division: adhesion and proliferation of Chinese hamster ovary (CHO)
cells. We used both wild-type (CHO-K1) cells and a mutant (CHO-
745) which is deficient in the synthesis of proteoglycans due to lack of
activity of xylosyl transferase. Using different amounts of wild-type
and mutant cells, little adhesion was observed in the presence of
laminin and type I collagen. However, when fibronectin or vitronectin
was used as substrate, there was an enhancement in the adhesion of
wild-type and mutant cells. Only CHO-K1 cells showed a time-
dependent adhesion on type IV collagen. These results suggest that the
two cell lines present different adhesive profiles. Several lines of
experimental evidence suggest that heparan sulfate proteoglycans
play a role in cell adhesion as positive modulators of cell proliferation
and as key participants in the process of cell division. Proliferation and
cell cycle assays clearly demonstrate that a decrease in the amount of
glycosaminoglycans does not inhibit the proliferation of mutant CHO-
745 cells when compared to the wild type CHO-K1, in agreement with
the findings that both CHO-K1 and CHO-745 cells take 8 h to enter the
S phase.
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Introduction
Heparan sulfate proteoglycans are ubiq-
uitously present on the cell surface and in the
extracellular matrix (ECM). The major cell
surface proteoglycan families are syndecans
and glypicans. The expression of heparan
sulfate proteoglycans is cell type specific
(1), and different cells can express specific
core protein with heparan sulfate (HS) chains
of distinct disaccharide sequences and bind-
ing properties (1). Studies with different tis-
sues and cell lines during the last decade
have revealed the putative roles of heparan
sulfate proteoglycans in cell adhesion, modu-
lation of growth factor activities, and ECM
organization. All of these roles are mediated
by interactions with extracellular and cyto-
plasmic ligands (2).
HS chains contain the same disaccharide
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units albeit in different proportions among
organisms as diverse as insects, mollusks,
and mammals. The conservation of HS bind-
ing by extracellular proteins suggests that
their association with HS is ancient and func-
tionally relevant (3).
HS has been implicated in a variety of
biological processes including the regula-
tion of glomerular basement membrane per-
meability, the assembly of basement mem-
branes, the regulation of nuclear metabolism
(4), blood coagulation (5), viral and bacte-
rial infection (6), and tumor cell malignancy
(4). Several disease conditions such as car-
diovascular diseases (4) and diabetes (7) are
associated with changes in the expression of
proteoglycans as well as with structural and
functional alterations of their glycosami-
noglycan chains. HS chains are known to
interact with a variety of proteins such as
heparin-binding growth factors, ECM, se-
lectins, protease inhibitors and lipoprotein
lipase (4) and are thereby implicated in vari-
ous cell processes. HS binds to and regulates
the activity of growth factors, cytokines, su-
peroxide dismutase and antithrombin, which
contribute to aberrant cell proliferation, mi-
gration and matrix production (4). They are
clearly involved in adhesion, morphological
regulation during development, remodeling
and changes in cell shape (8-10).
Effect of heparan sulfate on cell
adhesion
Cell adhesion plays a key role in the
maintenance of tissue organization in multi-
cellular organisms. Cell adhesion requires
HS-ligand binding and direct or indirect in-
teractions of core protein with cytoskeletal
and signaling molecules. The ECM ligands
bind to cell surface heparan sulfate proteo-
glycans and cause actin filament reorganiza-
tion (4). The interaction of HS chains with
extracellular ligands may help the formation
of proteoglycan clusters, which appears to
be critical for focal adhesion formation (4).
Focal adhesions in many cell types grown on
various substrates contain syndecan-4 (11).
HS binding to cell adhesion molecules and
syndecans localized at adherens junctions
(4) show that cell surface heparan sulfate
proteoglycans mediate physiological cell-cell
interactions. HS binds the immunoglobulin
superfamily of adhesion molecules PECAM-
1 and N-CAM (4). Cell surface-associated
heparan sulfate proteoglycans, predominantly
perlecan, are involved in the process of bind-
ing and endocytosis of thrombospondin-1 by
vascular endothelial cells (12).
Cell attachment is a reaction that de-
pends on time of incubation as well as on the
concentrations of cell surface receptors and
ligands. Since cell surface proteoglycans have
been proposed to participate in cell adhesion
processes, we have examined the attachment
of wild-type (CHO-K1) and mutant (CHO-
745) cells that are unable to synthesize pro-
teoglycans to wells coated with fibronectin
(FN) at different concentrations and times of
exposure (Figure 1). The different strains
behaved almost identically, i.e., wild-type
and mutant cells attached to a fixed amount
of FN in a time-dependent reaction that was
completed in @40 min for wild-type and @60
min for mutant cells (Figure 1A). Both cells
also attached similarly to limiting amounts
of FN adsorbed in the wells (Figure 1B).
Wells coated with <4 µg FN allowed only
submaximal numbers of cells to attach. We
also demonstrated that both cell lines show
poor adhesion to laminin (LN) and type I
collagen. This was observed with a limited
number of cells. On the other hand, there is a
change in cell adhesion in the presence of
FN and vitronectin (VN) when the mutant
cells are plated at higher concentrations. The
results of our study suggest that although
negligible amounts of glycosaminoglycans
are present in mutant CHO-745 cells, their
attachment to some ECM components (FN
and VN) is not affected (Figure 2). When
type IV collagen was the substrate, CHO-K1
demonstrated a time-dependent cell adhe-
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Figure 1. Attachment of wild-
type (CHO-K1) and mutant
(CHO-745) cells to fibronectin
substrates as a function of fi-
bronectin concentration and
time. Cell attachment was
quantified after staining the
cells with 0.8% crystal violet in
20% ethanol, washing with
PBS, pH 7.4, eluting the dye
with 0.1 M sodium citrate and
ethanol (1:1), pH 4.2, and meas-
uring absorbance at 550 nm.
Data are reported as mean ±
SD of four determinations. A,
Cells (5 x 105 or 2 x 105 in F-12
medium) were seeded onto 24-
well plates coated with 10.0 µg/
ml fibronectin and incubated for
different periods of time as in-
dicated. Nonadhesive sub-
strates were prepared by coat-
ing the wells with 1% BSA. B,
Cells (2 x 105 or 5 x 105 in 0.5
ml F-12 medium) were seeded
onto 24-well plates coated with
0.5, 1.0, 2.0, 4.0, 6.0, 8.0, and
10.0 µg/ml well fibronectin and
incubated for 40 and 150 min.
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sion. Furthermore, little adhesion observed
in CHO-745 cells was not time-dependent
(Figure 2).
Heparan sulfate proliferation and
cell cycle
Several studies have suggested that hep-
aran sulfate proteoglycans are involved in
the control of cell growth (8-10,13). Cell
proliferation and differentiation are regu-
lated by a broad range of growth factors and
cytokines, many of which bind heparin or
HS with a relatively high affinity (14), regu-
lating cell proliferation and differentiation.
These include the family of fibroblast growth
factors (FGF), hepatocyte growth factor,
platelet-derived growth factor, vascular en-
dothelial growth factor (VEGF), g-interferon,
and various chemokines (13,15). These mol-
ecules bind to high-affinity cell surface re-
ceptors, but in many cases, efficient signal
transduction also requires HS, since in mu-
tant cell lines lacking heparan sulfate proteo-
glycans or in cells treated with chlorate or
heparitinase, cellular responses are dramati-
A
B
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cally decreased (16). Syndecans-1, -2 and -4
as well as glypican-1 possess HS which carry
out this function (17). The action of HS as a
positive modulator of cell proliferation is
due to its capacity to bind and act as co-
receptor for growth factors, such as FGF
(14). VEGF, FGF, heparin-binding epider-
mal growth factor, interleukin-3, and g-inter-
feron form strong complexes with heparan
sulfate proteoglycans (18). The crystal struc-
tures of FGF-2 and heparin oligosaccharides
show specific interactions between Asp28,
Arg121, Lys126, and Gln135 of the growth fac-
tor and the iduronic acid 2-O-sulfate and
glucosamine N-sulfate residues as well as
other carboxyl groups present in the heparin
oligosaccharides (19).
HS can participate in the process of cell
division in two different ways, either as a
modulator or in response to a mitogenic
stimulus (14). A significant decrease in HS
is observed in regenerating rat liver after
partial hepatectomy. The peak of mitotic
activity coincided with the smallest amounts
of HS (13). It was also shown that increased
HS synthesis mediated by protein kinase C
inhibits cell proliferation in endothelial cells
in culture. On the other hand, a decrease of
Figure 2. Adhesion of of wild-
type (CHO-K1) and mutant (CHO-
745) cells to different matrix pro-
teins. Attachment of CHO-K1
and CHO-745 cells to substrates
containing laminin, collagen I, fi-
bronectin, vitronectin or collagen
IV. Cells (2 x 105 or 5 x 105 in 0.5
ml F-12 medium) were seeded
onto 24-well plates coated with
10 µg/ml of the different matrix
proteins and incubated at 37oC
for the indicated periods of time.
Nonadhesive substrates were
prepared by coating the wells
with 1% BSA previously heat-
treated at 56oC for 60 min. Cell
attachment was quantified after
staining the cells with 0.8% crys-
tal violet in 20% ethanol, wash-
ing with PBS, pH 7.4, eluting the
dye with 0.1 M sodium citrate
and ethanol (1:1), pH 4.2, and
measuring absorbance at 550
nm. The comparison of attach-
ment was possible because both
cell types show similar absorb-
ance (0.8% crystal violet) for the
same number of cells (1 x 105 to
1 x 106).
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surface HS was observed at the G1 phase of
the cell cycle (20). Corroborating the previ-
ous observations for endothelial cells (20),
the present results clearly demonstrate that a
diminished amount of glycosaminoglycans
does not inhibit the proliferation of mutant
CHO-745 cells, which is similar to that of
the wild-type CHO-K1 (data not shown).
Both cell types enter and progress through
the S phase after about 8 h. It is interesting to
note that the wild-type CHO-K1 cell has a
slightly higher cell proliferation than the
mutant CHO-745 cell type when we analyze
the number of cells (data not shown). This
could possibly explain why wild-type CHO-
K1 incorporates more thymidine (data not
shown).
Cell adhesion is a process dependent on
intact proteoglycan molecules since it re-
quires both HS-ligand binding and direct or
indirect interactions of the protein core with
cytoskeletal and/or signaling molecules (2).
The use of the HS-deficient mutant CHO-
745 and the wild-type CHO-K1 demonstrated
that heparan sulfate proteoglycans were not
involved in cell adhesion to FN, VN, LN and
type I collagen or in cell cycle and cell
proliferation. Finally, our results strongly
suggest that adhesion of the cells to type IV
collagen is dependent on heparan sulfate
proteoglycans since the mutant cell line lacks
this property.
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